Key facts
- MPM BioImpact LLC filed SCHEDULE 13G/A for DBV TECHNOLOGIES S.A. Ordinary Shares, nominal value 0.10 euro per share (DBVT).
- Disclosed ownership: 8.8%.
- Date of event: 31 Mar 2026.
MPM BioImpact LLC - 31 Mar 2026 SCHEDULE 13G/A Report for DBV TECHNOLOGIES S.A. Ordinary Shares, nominal value 0.10 euro per share (DBVT)
- Filing Manager
- MPM BioImpact LLC
- Reporting Manager
- MPM BioImpact LLC
- Symbol
- DBVT
- Shares outstanding
- 296,213,705 shares
- Disclosed Ownership
- 26,066,806 shares
- Ownership
- 8.8%
- Form type
- SCHEDULE 13G/A
- Filing time
- 15 May 2026, 16:09:40 UTC
- Date of event
- 31 Mar 2026
- Previous filing
- 17 Feb 2026
- SEC
- View on sec.gov
Key filing fact
MPM BioImpact LLC disclosed 8.8% ownership in DBV TECHNOLOGIES S.A. Ordinary Shares, nominal value 0.10 euro per share (DBVT) on 31 Mar 2026.
Change
- Previous schedule filing date: 17 Feb 2026.
- Current filing was accepted on 15 May 2026, 16:09.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (1)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| MPM BioImpact LLC | 8.8% | 26,066,806 | 26,066,806 | 0 | Christopher Wolf | Chief Financial Officer |
CIK / CUSIP context first